Search for: "State v. Tri-State Pharmaceutical" Results 281 - 300 of 455
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Jan 2014, 7:21 am by John Elwood
Merrell Dow Pharmaceuticals, Inc. [read post]
6 Mar 2018, 11:17 am by Kevin
According to this report, state officials seized the machine last year and auctioned it off to help pay his tax debt (it went for $65k, if you’re wondering). [read post]
1 Jun 2010, 8:16 am by law shucks
After practicing in the area of intellectual property litigation and counseling for several years, he left private practice to serve as an Assistant United States Attorney in the Southern District of New York, where for three years he tried criminal jury trials for the federal government. [read post]
5 Aug 2021, 12:12 pm by Lawrence B. Ebert
(collectively, GSK) sued Teva Pharmaceuticals USA, Inc. in the United States District Court for the District of Delaware for infringement of claims of GSK’s Reissue Patent No. [read post]
9 Jan 2013, 6:06 pm by Jessica Mendelson
Pharmaceutical Company Trade Secrets to United States Subsidiary of a Chinese Company – In January 2012, a former employee of an American pharmaceutical company, pled guilty to stealing trade secrets and making them available to an American subsidiary of a Chinese company. [read post]
24 Jan 2014, 11:00 am
  (Some requirements for expert testimony really are substantive state law, but that is a different issue.) [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
Although the Court of Appeal was clear, in Neurim v Generics [2020] EWCA Civ 793, that deciding to uphold the lower court’s decision not to grant a pharmaceutical patent PI was based on the specific facts of that case, the Patents Court has subsequently refused two further pharmaceutical PIs (Neurim v Teva [2022] EWHC 954 (Pat) and [2022] EWHC 1641(Pat), and Novartis v Teva [2022] EWHC 959 (Ch)). [read post]
21 May 2015, 10:39 am
 The parties have been back in court to fight over other patents, resulting in the decision Synthon B.V. v Teva Pharmaceutical Industries Ltd [2015] EWHC 1395 (Pat), which came out this morning.The patents concerned are EP (UK) 2 177 528 and EP (UK) 2 361 924, both divisionals of EP (UK) 1 799 703, which was revoked by the EPO in opposition proceedings pursuant to Teva's withdrawal of it after a negative preliminary opinion. [read post]